Contact this trialFirst, we need to learn more about you.
PD-L1 Inhibitor
Monalizumab or Oleclumab with Durvalumab and Radiation for Lung Cancer
Recruiting1 awardPhase 1
Troy, Michigan
This trial is testing two different radiation schedules with durvalumab to see which is better at treating NSCLC.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service